Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 August 2006, Vol. 108, No. 3, pp. 821-829.
Prepublished online as a Blood First Edition Paper on April 11, 2006; DOI 10.1182/blood-2005-11-006817.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2005-11-006817v1
108/3/821    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bennett, R. L
Right arrow Articles by May, W S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bennett, R. L
Right arrow Articles by May, W S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted November 30, 2005
Accepted March 11, 2006

RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy and viral infection

Richard L Bennett, William L Blalock, Dean M Abtahi, Yu Pan, Sue A Moyer, and W Stratford May*

University of Florida, Shands Cancer Center
Department of Immunology and Molecular Genetics, University of Florida

* Corresponding author; email: smay{at}ufscc.ufl.edu.

While the interferon-inducible dsRNA-dependent protein kinase PKR is reported to initiate apoptosis in some instances, the mechanism by which diverse stress stimuli activate PKR remains unknown. Now we report that RAX, the only known cellular activator for PKR, initiates PKR activation in response to a broad range of stresses including serum deprivation, cytotoxic cytokine or chemotherapy treatment or viral infection. Thus, knock- down of RAX expression by 80% using siRNA prevents IFN{gamma}/TNF{alpha} -induced PKR activation and eIF2{alpha} phosphorylation, I{kappa}B degradation, IRF-1 expression and STAT1 phosphorylation, resulting in enhanced MEF cell survival. In contrast, expression of exogenous RAX, but not of the nonphosphorylatable, dominant-negative RAX(S18A) mutant, sensitizes cells to IFN{gamma}/TNF{alpha}, mitomycin C, or serum deprivation in association with increased PKR activity and apoptosis. Furthermore, RAX(S18A) expression in Fanconi anemia complementation group C null MEF cells not only prevents PKR activation but also blocks hypersensitivity to IFN{gamma}/TNF{alpha} or mitomycin C that results in enhanced apoptosis. In addition, reduced RAX expression facilitates productive viral infection with VSV and promotes anchorage-independent colony growth of MEF cells. Collectively these data indicate that RAX may function as a negative regulator of growth that is required to activate PKR in response to a broad range of apoptosis-inducing stress.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. H. Kok, M.-H. J. Ng, Y.-P. Ching, and D.-Y. Jin
Human TRBP and PACT Directly Interact with Each Other and Associate with Dicer to Facilitate the Production of Small Interfering RNA
J. Biol. Chem., June 15, 2007; 282(24): 17649 - 17657.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Yang, S. Wu, X. Su, and W. S. May
JAZ mediates G1 cell-cycle arrest and apoptosis by positively regulating p53 transcriptional activity
Blood, December 15, 2006; 108(13): 4136 - 4145.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020